At close: 4:08:20 PM GMT+8
Breakdown
12/31/2023
12/31/2022
12/31/2021
Total Assets
1,706,797.000
1,446,805.000
1,494,881.000
Total Liabilities Net Minority Interest
357,758.000
2,693,121.000
2,285,390.000
Total Equity Gross Minority Interest
1,349,039.000
-1,246,316.000
-790,509.000
Total Capitalization
1,409,039.000
-1,246,316.000
-790,509.000
Common Stock Equity
1,349,039.000
-1,246,316.000
-790,509.000
Capital Lease Obligations
54,344.000
54,128.000
26,531.000
Net Tangible Assets
1,341,157.000
-1,247,410.000
-791,925.000
Working Capital
1,161,528.000
1,068,023.000
1,382,475.000
Invested Capital
1,538,450.000
-1,246,316.000
-790,509.000
Tangible Book Value
1,341,157.000
-1,247,410.000
-791,925.000
Total Debt
243,755.000
54,128.000
26,531.000
Share Issued
304,024.465
304,024.465
304,024.465
Ordinary Shares Number
304,024.465
304,024.465
304,024.465
12/31/2021 - 6/12/2023
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
2162.HK Keymed Biosciences Inc.
34.550
-8.84%
1477.HK OCUMENSION-B
4.710
-2.48%
2315.HK Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
8.100
+2.14%
1541.HK IMMUNEONCO-B
6.140
+1.99%
6990.HK Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
179.400
-4.37%
2105.HK Laekna, Inc.
10.840
-8.75%
1521.HK FRONTAGE
1.560
+3.31%
1952.HK Everest Medicines Limited
49.000
+3.38%
3759.HK Pharmaron Beijing Co., Ltd.
13.900
-2.66%
2171.HK CARsgen Therapeutics Holdings Limited
9.650
-0.31%